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The number of older patients admitted to peritoneal dialysis
(PD) programmes is growing. At the same time, there is
increasing data about the role of mesothelial cells in
determining the functional alteration of the peritoneum
during PD. However, little is known about the functional
changes accompanying the ageing process in mesothelial
cells. We aimed to evaluate whether the aging process is
accompanied by changes in some functional characteristic of
the human peritoneal mesothelial cells (HPMC), which could
account for the poor prognosis observed in old patients with
PD. HPMCs were isolated from patients undergoing a
nonurgent, nonseptic abdominal surgical procedure, without
renal, vascular or inflammatory disease. Cytokine levels
(by enzyme-linked immunosorbent assay (ELISA)),
nitratesþnitrites, and cyclooxygenase (COX) activity (by a
chemiluminescence assay), cytokines, COX, nitric oxide
synthase (NOS), and nuclear factor (NF)-jB1, two messenger
ribonucleic acid (mRNA) gene expressions (by reverse
transcriptase (RT)-Multiplex PCR), COX, and NOS promoter
gene activities, and NF-jB-dependent transcription (by
transient transfection assays) were determined. Our data
show a significant increase in cytokines, COX, and NOS
activities, and mRNA expression of cytokines, COX-2,
inducible nitric oxide synthase (iNOS) and precursors of
NF-jB in HPMCs from old people. This was also the
case for COX-2 and iNOS promoter gene activities and
NF-jB-dependent transcription. There was a positive
correlation between the age of the donor’s cell and the
proinflammatory profile of the HPMCs. Such age-dependent
increase (around two–three times) is partially abolished by
different antioxidant or free-radical scavengers. Thus,
aging is accompanied by the presence of an inflammatory
state in HPMCs, which involves the participation of different
reactive oxygen species.
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The proportion of old patients with end-stage renal disease
is growing, with the increased survival of populations in
Western societies. As a consequence, the incidence and
prevalence of old patients admitted to the renal replacement
therapy programmes are also increasing rapidly.1–3 Among
the therapeutic approaches to such a therapy, PD meets
some characteristics (haemodynamic stability, steady-state
metabolic control, independence from hospital visits and
avoidance of repeated vascular access) that seem to point it as
the best suited option for old patients.4 However, the scarce
data comparing the outcomes in old patients undergoing PD
vs haemodialysis show, with some few exceptions,5 a trend
toward a worst outcome in PD.6–9
Some studies suggest that mesothelial cells can be involved
in any of those poorest outcomes. In this regard, a high
permeability of the peritoneum has been documented in
elderly patients receiving continuous ambulatory PD, which
was the cause of a low serum albumin,10 a marker of the risk
of developing peritonitis.11 Recent data highlighting the role
of mesothelial cells in the structural and functional alter-
ations of the peritoneum during PD12 have shown that
mesothelial cells undergo some changes after dialysis is
initiated, and that inflammatory factors seem to play some
role in this cellular transdifferentiation.
The aging process is universal, it affects every postmitotic
cell and is accompanied by relevant morphologic and
physiologic changes. In vitro models of aging have been
developed for several human cell types, including fibroblasts,
endothelial cells, keratinocytes, and lymphocytes. Very little is
known about the senescence of HPMCs that form the largest
cell population in the peritoneal cavity, and play a crucial
role in intraperitoneal homeostasis and host defence. The
presence of the aging process has also been reported in these
cells, indeed with an increased rate compared to cells like
the fibroblasts, the other main cellular component of the
peritoneum.13 However, there are very few data about
functional changes accompanying the aging process in
mesothelial cells. The aim of this study is to evaluate how
the aging process is accompanied by changes in some
functional characteristics of mesothelial cells. These changes
could contribute or partially explain some of the clinical
outcomes observed in old people with PD. The aging process
http://www.kidney-international.org o r i g i n a l a r t i c l e
& 2006 International Society of Nephrology
Received 3 June 2005; revised 28 July 2005; accepted 11 August 2005
Correspondence: L Rodrı´guez-Man˜as, Unidad de Investigacio´n y Servicio de
Geriatrı´a, Hospital Universitario de Getafe, Ctra. de Toledo Km 12.5, Getafe,
Madrid 28905, Spain. E-mail: lrodri@hug.es
Kidney International (2006) 69, 313–322 313
shares many properties with low-grade inflammatory pro-
cesses (i.e. atherosclerosis), and this may also be the case in
this cell type. Even more, this possibility is enhanced by the
previously commented observations made in patients receiv-
ing PD, and more precisely in the oldest ones. Thus, we have
focused our research on two systems closely related to
inflammation (nitric oxide (NO) synthase and cyclooxygen-
ase (COX)), and on one of the most ubiquitous transcription
factor, nuclear factor kB (NF-kB), which takes part in the
inflammatory process, modulating the activity of these two
systems. We have also studied some of the potential
relationships among these components of the inflammatory
response. Finally, we studied the role of one of the most
common phenomena associated with aging (oxidative stress)
and whether this is involved in the activation of NF-kB and
in inflammation. The study was made in human omental
mesothelial cells from patients of different ages undergoing a
nonurgent, nonseptic abdominal surgical procedure.
RESULTS
Age and cytokines in human mesothelial cells
The levels of interleukin (IL)-1b, IL-6, and tumour necrosis
factor (TNF)-a were measured in the supernatant of
nonstimulated mesothelial cells. In every case, the concentra-
tions were higher in cells from elderly (465 years old) people
(old cells (OC)) than in younger ones (adult cells (AC))
(1871.50 vs 6.872.8 pg/ml, Pp0.001; 3275.5 vs 975 pg/
ml, Pp0.001; 108724.5 vs 52710 pg/ml, Pp0.001, for
IL-1b, IL-6, and TNF-a, respectively) (Figure 1a). Moreover,
there was a significant correlation between the age of the
donor and the levels of the basal cytokine production, mainly
for IL-1b (R2¼ 0.926; Po0.0001), but also for IL-6
(R2¼ 0.709; Po0.0001) and TNF-a (R2¼ 0.723; Po0.0001)
(Figure 1b).
In this same way, the expression of messenger ribonucleic
acids (mRNAs) of these cytokines and their receptors were
increased in cells from old people (mean age 7673 years)
compared with those obtained from the younger ones (mean
age 3876 years) (Figure 2).
Age and COX
We evaluated the basal levels of activity of a critical enzyme in
the inflammatory processes, COX, measured as relative
luciferase units (RLUs), in the whole cell protein extracts of
nonstimulated human peritoneal mesothelial cells (HPMCs).
The activity of COX was increased in OC compared with
AC (10 9257550 RLUs in OC vs 32617480 RLUs in AC;
Pp0.001) (Figure 3a), showing a strong correlation
(R2¼ 0.835; Po0.0001) between the age of the donors and
the activity of total COX (Figure 3a). We also measured the
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Figure 1 | Production of several proinflammatory cytokines in
unstimulated HPMCs. 5 105 HPMCs were grown in six-well plates
to confluence. The culture medium M-199 was then replaced by
vehicle medium, that is, serum-free medium supplemented with 0.1%
BSA for 12 h. (a) Levels of IL-1b, IL-6, and TNF-a were determined by
ELISA assay in cell culture supernatants under the manufacturer’s
specifications. (b) Correlation between age and levels of basal IL-1b,
IL-6, and TNF-a, respectively. *Pp0.05 vs the o65 years group.
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Figure 2 | Age-associated increase of proinflammatory cytokine
mRNA gene expressions in unstimulated HPMCs. mRNA gene
expressions of IL-1b, IL-6, IL-6R, TNF-a, TNF-R1, and TNF-R2 were
carried out by RT-MPCR. A representative blot and densitometric
values of the ratios for corresponding mRNAs and GAPDH mRNA are
shown. *Pp0.05 vs the o65 years group.
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basal mRNA expression of the two isoenzymes separately,
COX-1 and COX-2. They showed a different behaviour.
While we did not find any change in the ratio mRNA COX-1/
mRNA GADPH (0.7670.23 arbitrary units in OC vs 0.787
0.13 arbitrary units in AC, P¼ 0.82) (Figure 3b), the ratio
mRNA COX-2/mRNA GADPH increased nearly two-and-a-
half fold in OC compared with the cells obtained from the
younger donors (0.7970.21 in OC vs 0.3270.22 in AC;
Pp0.001) (Figure 3b). As in cytokines, there was a strong
correlation (R2¼ 0.69; Po0.0001) between the age of the
donors and the expression of COX-2 mRNA (Figure 3b, right).
To further characterize this finding, and by using transient
transfection techniques, we also studied the activity of two
reporter plasmids bearing the human COX-1 and a short
(327/þ 59 bp) human COX-2 promoter. As in mRNA, the
activity of the luciferase-based promoter construct was
essentially the same at any age for COX-1 (80807258 RLUs
in OC vs 78007426 RLUs in AC, P¼ 0.69) (Figure 3c), but
showed a remarkable dependency upon age in the case of this
short COX-2 promoter construct, increasing its activity in
OC around three-fold as compared to the mesothelial cells
from people younger than 65 years old (10 50173101 RLUs
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Figure 3 | Effect of age on COX-isoenzyme activity and gene expressions in unstimulated HPMCs. (a) Chemiluminescence determination
of total COX activity in whole cell protein extracts. (b) Representative blots and densitometric values of the ratios for corresponding COX
mRNAs and GAPDH are shown. (c) Transient transfection assays with 2 mg of each plasmid, phCOX-2(327/þ 59)-luc or phCOX-1(1010/þ 59)-
luc were performed. (a, right) Correlation between age and activity of total COX, (b, right) values of ratios for COX-2/GAPDH mRNAs and
(c, right) RLUs of basal COX-2 promoter activity are shown. *Pp0.05 vs the o65 years group.
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in OC vs 344671788 RLUs in AC; Pp0.001) (Figure 3c) and
showing a good correlation (R2¼ 0.551; Po0.0001) among
those variables (age and COX-2 promoter–reporter activity)
(Figure 3c, right).
Age and NO system
The third component of the inflammatory response that we
have studied is the NO system. For this purpose, we initially
evaluated the levels of NO measured as nitritesþ nitrates
(NOx) for 24 h at the cell culture supernatants of non-
stimulated HPMCs and the expression and activity of NO
synthases as the activity of their promoter constructs in
transiently transfected HPMCs. As with COX, we separately
studied the constitutive (endothelial nitric oxide synthase
(eNOS)) and the inducible (inducible nitric oxide synthase
(iNOS)) isoenzymes. In every case we studied the basal
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Figure 4 | Effect of age on NO production and on NOS-isoenzyme gene expressions in unstimulated HPMCs. (a) NOx measurements were
made in unstimulated HPMC supernatants. (b) Representative blots and densitometric basal values of the ratios for corresponding NOS mRNAs
and GAPDH were performed by RT-MPCR. (c) Transient transfection assays with 2 mg of each of p7.2-hiNOS-luc or p1.01-heNOS-luc and reporter
plasmids were performed. (a, Right) correlation between age and NOx levels, (b, right) values of ratios for iNOS/GAPDH mRNAs, and (c, right)
values for iNOS promoter activity are shown. *Pp0.05 vs the o65 years group.
316 Kidney International (2006) 69, 313–322
o r i g i n a l a r t i c l e J Nevado et al.: Aging and mesothelial cells
situation, not using substances to stimulate or modulate the
activity or expression of any of them.
The activity of NO synthase, measured by the levels of
NOx, was increased in OC compared with AC (36.4277.99
vs 13.6275.55 mM in AC; Pp0.001) (Figure 4a). This
increased activity was due to iNOS. The ratio iNOS
mRNA/GAPDH mRNA was higher in cells from old donors
(0.95870.10 arbitrary units) than in cells from younger adult
people (0.41270.26 arbitrary units; Pp0.001) (Figure 4b).
On the contrary, eNOS activity not only did not increase
but also showed a statistically significant decrease. The
ratio eNOS mRNA/GAPDH mRNA was lower in OC than
in AC (0.2170.07 vs 0.4970.15 arbitrary units; P¼ 0.011)
(Figure 4b). In agreement with these data, we found a signi-
ficant correlation among age and NOx levels (R2¼ 0.796;
Po0.0001), iNOs (R2¼ 0.664; Po0.0001) (Figure 4a and b,
right), and eNOS mRNA levels (R2¼ 0.43; Po0.01) (data
not shown).
Supporting these findings, the activity of the iNOs and
eNOS luciferase-based promoter constructs was parallel to
that shown by the respective mRNA gene expressions. Thus,
iNOs promoter activity was higher in advancing age
(415171080 vs 22757350 RLUs; Po0.001) (Figure 4c, left),
with a positive correlation among age and promoter activity
(R2¼ 0.653; Po0.0001) (Figure 4c, right), while eNOS
promoter activity was lower in cells from old people
compared with cells from younger adult people (12257400
vs 31057766 RLUs; Po0.001; R2¼ 0.703; Po0.0001)
(Figure 4c, left, and data not shown, respectively).
Age and NF-jB
We also studied one of the main transcription factors
involved in the inflammatory response, the NF-kB. For this
purpose, we determined NF-kB-dependent trancription basal
activity in OC as well in AC transiently transfected with
p5NF-kB-luc. Once again, we detected an increased
age-dependent NF-kB activity. Mean values were higher
in OC than in AC (18 75073500 vs 700071700 RLUs;
Po0.001), and a strong correlation was observed between age
and NF-kB-dependent trancriptional activity (R2¼ 0.853;
Po0.0001) (Figure 5a, right).
We additionally analysed the effect of age on mRNA levels
of p50/105 (NF-kB1) and p49/100 (NF-kB2) in HPMCs.
The best-characterized form of NF-kB is comprised of
a heterodimer of 50 kDa (p50/NF-kB1) and 65 kDa (p65/
RealA) proteins. RT-Multiplex PCR (MPCR) assays revealed
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an increased band ratio NF-kB1, 2 mRNAs/GAPDH mRNA
in OC vs AC (1.4870.31 vs 0.5470.25 arbitrary units,
respectively, Po0.001) (Figure 5b), and a significant correla-
tion was observed between age and NF-kB1, 2 mRNA gene
expressions (R2¼ 0.806; Po0.0001) (Figure 5b, right).
Effect of reactive oxygen species scavengers, indomethacin
and pyrrolidine dithiocarbamate
Finally, we tried to establish a cause–effect relationship
among the several substances shown to be involved in the
changes observed in HPMCs with aging. To elucidate the
possible mechanism(s) acting as mediator(s) on the age-
dependent increased activity of NOx, NF-kB-dependent
transcription and iNOS or COX-2 luciferase-based reporters
observed in HPMCs from old people, we evaluated the effect
of scavenging reactive oxygen species (ROS), the inhibition of
COX and the inhibition of the NF-kB-dependent transcrip-
tion on NF-kB activity, iNOS promoter activity and NOx
levels in cells isolated from the elderly. The hand Right side of
Figure 6 shows that all of the ROS scavengers used,
indomethacin, as well as pyrrolidine dithiocarbamate
(PDTC), reduced in a very similar percentage the activity
of NF-kB-dependent transcription, iNOS promoter and NOx
levels in OC (mean age 7673 years). In the experimental
conditions used, neither PDTC nor all ROS scavengers (used
at the same concentrations as those used in the experiments
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Figure 6 | Effect of different substances on the changes observed in HPMCs in the elderly. (a–c, right) HPMCs from the elderly (OC, mean
age 7673 years) and (a–c, left) younger adults (AC, mean age 38.5717.5) were transiently transfected with 2 mg of the luciferase-based
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carried out in OC) significantly modified basal NF-kB
transcriptional activity, basal iNOS promoter activity and
basal NOx levels in younger adults with AC (mean age
38.5717.5 years) (Figure 6a–c, left).
DISCUSSION
In this study, we describe that aging is accompanied by the
presence of several significant changes in the functional
profile of the HPMCs regarding their activity as a cell
potentially involved in the generation of inflammatory events
within the peritoneum. These changes seem to be causally
related among them, as suggested by the effect of inhibiting
COX on the NO system, and the participation of ROS as well.
The capacity of peritoneal cells from animals14 and in
HPMCs15,16 to produce several cytokines in basal or
stimulated conditions has been described some years ago.
More recently, the same has been shown for another system
involved in the tissue inflammatory response, the NO
system.17 Although inflammation has been implicated in
several pathological scenarios, including atherosclerosis, its
potential role in the changes observed in physiological
processes such as aging is less known. Many experimental
data have confirmed the role of inflammation during the
aging process in several tissues, but there are no data about
that topic in the human peritoneum.
To our knowledge, this is the first report investigating the
differences in some characteristics related to inflammation
according to the age of the cell’s donor in the absence of
inflammatory stimuli in vivo or in vitro. In our study, we
show that in basal, unstimulated conditions, HPMCs show
an inflammatory phenotype that is age dependent. These
changes have been observed in the absence of any known
condition promoting inflammatory changes. Moreover,
people from whom peritoneum and mesothelial cells were
obtained suffered from the same nonseptic surgical proce-
dures. Excluding their surgical diagnosis, they did not have
any other relevant medical condition, including cardiovas-
cular diseases or risk factors, nor were they taking drugs that
could potentially interfere with our results, including
nonsteroidal anti-inflammatory drugs and antioxidants.
Thus, the main difference between the samples was the age
of the persons they were obtained from.
These changes embrace several components and molecules
of the inflammatory cascade. The mechanisms taking part in
these changes are modulated pretranscriptionally, as shown
by the experiments of transitory transfection using different
luciferase-based promoter constructs. In this regard, an
increase in the activity of the promoter genes of the two
systems studied (nitric oxide synthase (NOS) and COX) has
been clearly shown in cells from old people, but not in those
from adult persons. Moreover, the two components of those
systems that exhibited some changes were the ones usually
involved in the inflammatory responses iNOS and COX-2,
while the mainly constitutive enzymes did not show any
change or, indeed, decreased their expression. Furthermore,
this change in the expression of mRNA has functional
implications, as shown by the increased activity of COX and
NOx production as well in HPMCs from old donors, as
compared with those from younger adult ones.
NF-kB plays a central role in the mechanisms controlling
the inflammatory responses in several ways.18,19 Indeed,
NF-kB increased its activity and also showed a higher
expression of NF-kB1, and/or NF-kB2 mRNAs, in cells from
old subjects than in cells from younger adults, paralleling the
results observed with cytokines, COX-2, and iNOS. NF-kB
seems to exert a regulatory role in this process, as shown by
the changes induced by the preincubation of HPMCs with its
inhibitor PDTC on the NO system. Moreover, the regulatory
mechanisms controlling this transcriptional factor are
diverse, ranging from ROS to molecules whose synthesis is
regulated by the same NF-kB (iNOS, COX). In HPMCs, NF-
kB activity was decreased by several ROS scavengers, but also
by indomethacin, suggesting that there are many regulatory
mechanisms involved in these changes raising complex routes
with their activities being regulated by one another. With our
data it is not possible to establish a linear source of activation.
On the contrary, our data suggest that oxidative stress and
inflammation can positively modulate one other, acting as a
mutual amplifying mechanism, with NF-kB playing a key
role in this mechanism of activation. This nonlinear
regulatory mechanism of the inflammatory processes is usual
in other tissues,19 but also in HPMCs,20 suggesting that once
the process is initiated the participating and signaling
mechanisms are very unspecific, whatever was the trigger.
These findings may have clinical significance, raising a
potential explanation for the increased complications related
to PD in old people. It is remarkable that among the predictive
factors for the development of a decrease in filtration capacity,
peritoneal inflammation is one of the most relevant.21,22 In
this regard, the functional longevity of the peritoneum in
patients requiring PD is highly related to the rate of peritoneal
inflammation.21 The presence of an inflammation in basal
conditions due to age may account for the higher rate of
filtration failure and infectious complications in old patients
with PD, compromising the election of dialysis modality in
spite of the best ratings obtained by PD when patients are
asked about their preferences.23 However, the finding that one
of the two main components of the peritoneal cells
(mesothelial cells) shows an inflammatory phenotype as it
ages jointly with the fact that senescence is more prominent in
these cells than in other cells of the peritoneum (fibroblasts)13
also offers some opportunities for therapeutic intervention.
These potential therapeutic interventions, targeted to limit the
inflammatory component, may range from drug regimens
(including anti-inflammatory therapies) to the election of
dialysis solutions.12
CONCLUSION
In summary, we show that aging is accompanied by the presence
of an inflammatory state in HPMCs, reaching its maximal
activity in old people. This inflammatory state is regulated by
common and well-known mechanisms, offering opportunities
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to therapeutic interventions to improve the outcomes in old
patients with end-stage renal disease and receiving PD.
MATERIALS AND METHODS
Materials
Culture plastic -ware was obtained from Corning-Costar (New York,
NY, USA). M199 medium with 25 mM N-2-hydroxyethylpiperazine-
N0-2-ethanesulphonic acid/Hank’s salt, L-glutamine and streptomy-
cin/penicillin solution were from Biochrom KG (Berlin, Germany).
Phosphate-buffered saline, foetal calf serum (FCS) and trypsin-
ethylenediamine tetraacetate (EDTA) solution were from Amresco
(Solon, OH, USA), Biological Industries (Beit-Hamek, Israel) and
GIBCO BRM (Paisley, UK), respectively. Monoclonal antibodies
against E-cadherin and von willebrand’s factor were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA, USA) and DAKO
laboratories (Hamburg, Germany), respectively. Taq DNA polymer-
ase and DNTP mixtures were from EGOGEN (Barcelona, Spain).
Unless otherwise stated, all other reagents and antibodies were
purchased from Sigma Chemical Co. (St Louis, MO, USA).
Establishment of HPMC culture
HPMCs were isolated from segments of omental tissue (1 g pieces)
from 15 different donors (mean age 54.6675.08; range 23–79 years)
undergoing nonurgent, nonseptic abdominal surgery (Table 1),
using methods described previously.24 Donors were free of any renal,
cardiovascular, inflammatory or peritoneal disease, and were not
taking anti-inflammatory drugs or antioxidants. The study was
approved by the Research Committee and by the Ethics Committee
of Clinical Research as well, both at the Hospital Universitario de
Getafe in Madrid.
HPMCs were routinely cultured in M199 containing 1 g/l of
D-glucose and supplemented with 10% FCS, 100mg/ml strepto-
mycin, 100 U/ml penicillin and 2.5mg/ml amphotericin. At confluence,
HPMCs were passaged using a 0.02% EDTA–0.05% trypsin solution
and split in 1:2 ratio. Mesothelial cell characterization was based on
both cell morphology and indirect immunofluorescence staining of
several human mesothelial markers (Table 2). Human aortic smooth
muscle cells, human umbilical vascular endothelial cells and human
aortic endothelial cells, used as controls of the different markers
tested, were obtained using methods described previously.25,26 All
experiments were performed in passage 3–5. The morphologic and
staining features of the cells remain stable during these passages.
Ribonucleic acid isolation and RT-MPCR assays
Total RNA from HPMC (105–106 cells in 90-mm diameter Petri
dishes) was obtained using RNAquouss, from Ambion, Inc. (Austin,
TX, USA), following the manufacturer’s instructions. RT and MPCR
were performed following manufacturer’s instructions (Maxim
Biotech. Inc., San Francisco, CA, USA). In all, 1mg of complementary
deoxyribonucleic acid derived from RNA was used from each
Multiplex polymerase chain reaction. MPCR kit has been designed
to direct the simultaneous amplification of specific open reading
frame regions of different human NOS genes and GAPDH (hNOSG-
MPCR) or different human COX genes, NF-kB (NF-kB1, 2) and
GAPDH (hTNF-M052G-MPCR), or several cytokines genes such as
IL-6, IL-1b, TNF-a, IL-6R, TNF-R1, TNF-R2, and GAPDH genes
(h-Inflammation-M053G-MPCR). Levels of mRNA were normalized
to GAPDH transcript levels and expressed in relative densitometric
units, using a Chemi-Imager 5.5 from AlphaInnotec, CA, USA.
Reporter plasmids
The reporter plasmids used were 5NF-kB-luc (Stratagene,
La Jolla, CA, USA), and different luciferase-based reporter plasmids
corresponding to the 50 flanking regulatory regions of human iNOS
(7.2 kb hiNOS-luc)27 or human eNOS (1.33 kb heNOS-luc)28 or
short human COX-2 (phPES2-327/þ 59)29 or human COX-1 genes
(phPES1 1010/þ 69)29.
Transient transfection experiments
Transient transfection experiments were performed as described
previously.30 The transfection mixture consisted of 2 mg of the
above-mentioned plasmids incubated with 75 ml of DMEM and
7.5 ml of Superfects (Quiagen Gmbh, Hilden, Germany) in vehicle
medium, following the manufacturer’s instructions. Following
treatment with the specified agents, HPMCs were harvested and
lysed with passive lysis buffer and the extracts were assayed with a
luciferase reporter system (Promega; Madison, WI, USA). Luciferase
activity was expressed as RLUs.30
Measurement of nitrite plus nitrate as NOS activity
Nitrite plus nitrate production (NOx) was measured by an ozone-
chemiluminescence method in confluent HPMC (5 105 cells),
using a NO detector (NOAs 280 analyzer, Sievers, Boulder,
CO, USA). A standard curve was generated by injections of known
Table 1 | Characteristics of the patients
Age Gender Diagnosisa Drugs
23 M Hepatic hydatidosis No
32 F Rectal cancer No
39 F Cholelitiasis Omeprazol
Lorazepam
Fluoxetin
42 F Rectal cancer No
44 F Rectal cancer No
46 F Colonic cancer No
55 M Colonic cancer No
56 M Gastric cancer No
58 M Pancreatic cancer No
60 M Rectal cancer No
61 M Rectal cancer Omeprazol
72 F Colonic cancer Lorazepam
Metamizol
76 F Cholelitiasis Bromazepam
77 M Pancreatic cancer No
79 M Gastric cancer Omeprazol
aPatients with a diagnosis of cancer were free of metastatic disease and peritoneal
involvement.
F, female; M, male.
Table 2 | HPMC characterization
Markers HPMC HAEC HUVEC HASMC
Factor VIII (vWF) +/
(diffuse)
+++
(granular)
+++
(granular)
Negative
a-Actin Negative Negative Negative +++
E-Cadherin ++ Negative Negative
VE-Cadherin +++ ++ ++
Vimentin +++ ++ ++
Cytokeratin 8 ++ ++ ++
Cytokeratin 18 ++ ++ ++
PECAM-1(CD31) Negative ++
HPMC, human peritoneal mesothelial cells; hAEC, human aortic endothelial cells;
HUVEC, human umbilical vascular endothelial cells; HASMC, human aortic smooth
muscle cells.
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concentrations of sodium nitrate. The levels of nitrite plus nitrate in
the cell culture supernatant were normalized to protein concentration
(1mg). Protein contents of the cell culture supernatants and whole cell
extract were determined using the BCA assay (Pierce, Rockford, IL,
USA).
Measurement of COX activity
Confluent cells were used to measure total COX activity by the
Cyclooxygenase Activity Kit (Stressgen Biotech, Madison, WA),
detecting the peroxidative activity of COX enzymes in protein
extract homogenates, as specified by the manufacturers, by a specific
chemiluminescence’s substrate. Light emission is directly propor-
tional to COX activity in the sample. Results are expressed as RLUs
normalized to protein content (1 mg).
Preincubation experiments
Some experiments were performed to elucidate the way by which
aging modified inflammatory mediators and effectors. For this
purpose, HPMCs were transiently transfected with the different
luciferase reporter plasmids described and afterwards incubated
during 12 h with several antioxidant agents (200 U/ml Cu–Zn
superoxide dismutase, 100mM tempol, 10mM vitamin C, 1 mM
dimethylthiourea and 200 U/ml catalase), indomethacin (10 mM) and
PDTC (100 mM). Following treatment with the specified agents, cell
culture supernatants were used to measure NOx, while cells were
harvested and lysed with passive lysis buffer for luciferase
determination under the manufacturer’s instructions.
Determination of cytokine levels
Cytokine levels in confluent cell (105 cells) culture supernatants were
determined using human TNF-a, IL-1b, and IL-6 Instant ELISAs
(The Bender Medsystems, Vienna, Austria), by generating a
standard curve provided by the manufacturer and normalized to
protein content (1mg).
Statistical analysis
Results are expressed as mean7s.e.m. The statistical analysis was
carried out using the StatView statistics programme (Abacus
Concepts, Inc., Berkeley, CA, USA). Differences in the mean or in
the variance were evaluated using the unpaired Student t-test or
factorial analysis of variance, as required. The results obtained from
the separate experiments conducted in every cell line were plotted
according to the age of the donors, and a simple regression analysis
was carried out to establish the potential correlation between age
and each variable of interest. A two-sided P-value o0.05 was
considered statistically significant. ‘n’ denotes the number of
experiments performed in triplicate, using cells obtained from at
least three different donors.
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